Mountain View, CA, June 28, 2023 (Globe Newswire) -- NeuroPace, a leading medical device company dedicated to improving the lives of epilepsy patients, has announced the appointment of Joel Becker as their new President & CEO. With a proven track record in commercial execution and experience in medical technologies, Becker will drive NeuroPace's growth to accelerate the adoption of their RNS® System.
Read full article here.
NY, NY, April 18, 2024 (Business Wire) -- Metsera, Inc., a pioneering player in the clinical-stage biopharmaceutical realm focusing on innovative treatments for obesity and metabolic ailments, has e
Cambridge, MA, April 23 2024 (PRNewswire) -- Flare Therapeutics Inc. has undergone a notable leadership transition with the selection of Dr. Douglas Manion, M.D., FRCP (C), as its newly appointed Ch
Wilmington, DE, April 23, 2024 (RTTNews) -- Incyte Corp. (INCY) is buying Escient Pharmaceuticals and its assets for $750 million, plus any cash left over when the deal closes. This acquisition need
